Splash Clinical Revenue and Competitors

Wauwatosa, WI USA

Location

#7765

Growjo Ranking

Pharma

Industry

Estimated Revenue & Valuation

  • Splash Clinical's estimated annual revenue is currently $6.2M per year.(i)
  • Splash Clinical's estimated revenue per employee is $201,000

Employee Data

  • Splash Clinical has 31 Employees.(i)
  • Splash Clinical grew their employee count by 94% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$7.6M3815%N/AN/A
#2
$32.4M1615%N/AN/A
#3
$30.2M1509%N/AN/A
#4
$82.4M410N/AN/AN/A
#5
$5.4M27-7%N/AN/A
#6
$11.7M58-5%N/AN/A
#7
$5.8M290%N/AN/A
#8
$8M403%N/AN/A
#9
$0.8M40%N/AN/A
#10
$10.1M500%N/AN/A
Add Company

Splash Clinical is an innovative patient recruitment firm that’s pioneered the use of digital & social media to recruit patients for clinical trials. The company was founded to help solve the problem of patient enrollment in clinical trials by leveraging the power of social media, data analytics and mobile technologies. Our team works with Sponsor’s and CRO’s from across the globe, supporting 5,000+ study sites in 19 countries. Over the past 7 years, Splash Clinical has proven successful completions of more than 300 digital & social media patient recruitment campaigns. Splash Clinical has a broad range of therapeutic experience including CNS, immunology, women’s health, oncology and rare & orphan disease states. With our extensive digital & social media knowledge, our campaigns reduce the time and diminish the expenses that are often required to recruit patients.

keywords:N/A

N/A

Total Funding

31

Number of Employees

$6.2M

Revenue (est)

94%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Splash Clinical News

2022-04-17 - First European Union Patient Dosed with 177Lu-PNT2002 in ...

POINT Biopharma's Phase 3 SPLASH trial in pre-chemo metastatic ... building a platform for the clinical development and commercialization of...

2022-04-06 - mRNA in the Spotlight as BioNTech Finally Makes a Splash in ...

By now, everyone in the science community is aware of the effectiveness of the messenger RNA (mRNA) vaccines developed by · At the Clinical...

2022-04-06 - Clinical Trials in Progress: PSMA-Based Radioligand, 177Lu ...

Charles Ryan is joined by Neil Fleshner to discuss the multi-center, open-label, phase III SPLASH study evaluating the efficacy of...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$6.7M3124%N/A
#2
$7.3M34-8%N/A
#3
$6M3644%N/A
#4
$9.3M363%N/A
#5
$4.3M370%N/A